Pharmadax Genesis
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $28M
Investors
- 3
About Pharmadax Genesis
Established in 2016 and based in Jiaxing, China, Pharmadax Genesis operates as a drug R&D CRO (Contract Research Organization) focuses on providing radioactive therapeutic drugs. The company mainly provides innovative drugs in nuclear medicine. Nuclear drug products include diagnostic drugs and therapeutic drugs. It has more than ten product pipelines, among which PMD11 and PMD12 are radioactive therapeutic drugs. Pharmadax Genesis also provides molecular imaging diagnosis. It has PharmadaX®? target molecule screening and targeted radiolabelled platform, and PharmadaX®? platform that combines proximal therapy and immunotherapy. The company generates revenue by providing molecular imaging diagnosis and innovative drugs in nuclear medicine. The company will use the funds for the research and development of existing pipelines and the construction of a radioactive drug industrialization base. The company expects to launch 6 to 8 new pipeline products between the end of 2024 and the first half of 2025, and will optimize its R&D platform in the next two to three years to build a full range of target molecule R&D capabilities. It also expects to complete the first phase of plant infrastructure construction by the end of 2025.
Who invested in Pharmadax Genesis
3 investors across 2 rounds
See all investors in Pharmadax Genesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pharmadax Genesis
Who invested in Pharmadax Genesis?
Pharmadax Genesis has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pharmadax Genesis raised?
Pharmadax Genesis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pharmadax Genesis last raise money?
Pharmadax Genesis's most recent round on record is a Series A, in Dec 2024.
What does Pharmadax Genesis do?
Established in 2016 and based in Jiaxing, China, Pharmadax Genesis operates as a drug R&D CRO (Contract Research Organization) focuses on providing radioactive therapeutic drugs.
Where is Pharmadax Genesis headquartered?
Pharmadax Genesis is headquartered in Jiaxing, China.
Which VCs invest in companies like Pharmadax Genesis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Pharmadax Genesis's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Pharmadax Genesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.